Literature DB >> 5017373

Plasma protein binding of diphenylhydantoin in patients with epilepsy. Agreement between the unbound fraction in plasma and the concentration in the cerebrospinal fluid.

L Lund, A Berlin, K M Lunde.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5017373     DOI： 10.1002/cpt1972132196

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  22 in total

Review 1.  Therapeutic drug monitoring of phenytoin. Rationale and current status.

Authors:  M Levine; T Chang
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

2.  Editorial: Clinical aspects of the blood-brain barrier.

Authors: 
Journal:  Br Med J       Date:  1976-07-17

3.  Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hormonal mediation of fetal rat bone resorption in vitro.

Authors:  T J Hahn; C R Scharp; C A Richardson; L R Halstead; A J Kahn; S L Teitelbaum
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

Review 4.  Anticonvulsant pharmacokinetics.

Authors:  A Breckenridge
Journal:  Proc R Soc Med       Date:  1974-01

5.  Anticonvulsant drugs. I. Patho-physiological and pharmacological aspects.

Authors:  H Kutt; S Louis
Journal:  Drugs       Date:  1972       Impact factor: 9.546

6.  Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.

Authors:  N Barth; G Alván; O Borgå; F Sjöqvist
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

Review 7.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

Review 8.  Plasma level monitoring of anticonvulsants.

Authors:  M J Eadie
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

9.  Salivary phenytoin radioimmunoassay. A simple method of the assessment of non-protein bound drug concentrations.

Authors:  J W Paxton; F Rowell; J G Ratcliffe; D G Lambie; R Nanda; I D Melville; R H Johnson
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

10.  Should we routinely measure free plasma phenytoin concentration?

Authors:  E M Rimmer; D C Buss; P A Routledge; A Richens
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.